Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Clinical trial NCT02220244 · UNKNOWN

Trial details

NCT number: NCT02220244
Sponsor: MedDay Pharmaceuticals SA
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2013-10-01
Primary completion: 2015-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.